new glp 1 coming out Retatrutide for weight loss: Study shows 30% body weight loss GLP4 coming out Eli Lilly

Consider this post the context-setting for the 2026 Health Populi TrendCast which youll see next week

The net benefit of GLP-1 receptor agonists in adults with overweight or obesity who do not have diabetes depends on their weight loss target and willingness to accept harms, according to researchers.Although GLP-1 receptor agonists have demonstrated effectiveness in reducing weight loss and risks for other chronic diseases, questions remain over whether the benefits outweigh the harms of the

Very impressed and will certainly continue to take them

Eligible Medicare beneficiaries can now access certain GLP-1 weight-loss drugs for about $50 a month through a pilot program running through next year.

Research published this week highlights tirzepatide outperforming other GLP-1 therapies in early type 2 diabetes treatment while separate studies identified autoantibodies as a likely biological driver behind persistent neurological symptoms in some long Covid patients.

Learn why the once-weekly schedule is vital for safety and how to manage side effects without changing your dose.